Actually, I don't fault the company on this one. AF jumped to a headline before reading the abstract carefully, and I pointed this out to him on twitter early in the morning. He has since amended his first article.
The abstract is pretty clear that they are reporting CRs and PRs for specific criteria, rather than overall CRs and PRs.
What you (and Feuerstein) may be overlooking is that this is not exactly GERN presenting; it's Dr. Tefferi. I'm sure Tefferi has looked at clinical response. I'm sure this question will come up on the CC today. It's certainly worth listening to the response.
Market Data 
Markets 
AI
